BUSM’s Carmela Abraham receives 2014 Massachusetts Neuroscience Consortium Award

Carmela Abraham, PhD, professor of biochemistry and pharmacology at Boston University School of Medicine, was the same of six recipients of this year’s Massachusetts Neuroscience Consortium Award wanting of nearly 60 applicants. The vouchsafe was awarded to her for her drudge on multiple sclerosis and the role of the life enlargement protein Klotho in the limited repair of spotless matter in the disease.

The Consortium gives the adjudge to those doing translational research in neurodegenerative and neuroinflammatory diseases–of that kind as Amyotrophic Lateral Sclerosis, Alzheimer’s ailment, Huntington’s disease, Multiple sclerosis, Parkinson’s indisposition, neuropathic pain and treatment-resistant hollowness.

Related Stories

Although Abraham has affectionate her entire career to the study of the molecular mechanisms leading to normal brain aging and the pathological processes that reach the highest point in Alzheimer’s, she discovered that Klotho is a neuroprotective protein that has beneficial movables in animal models of both Alzheimer’s and multiple sclerosis. Since Klotho is significantly reduced in the brain for the period of normal aging and in Alzheimer’s malady, Abraham and her colleagues searched on account of and identified molecules that can become greater Klotho levels in the brain. She is hoping to feat these molecules to create new treatments to hinder brain aging, neurodegenerative and neuroinflammatory diseases.

Abraham accepted her Bachelor of Science in biology from Tel Aviv University and her PhD in neuroscience from Harvard University. In joining to winning this award, she is the receiver of The Neuroscience Education and Research Foundation Award according to an Outstanding Promise as a Young Alzheimer Investigator (1990). She has accepted two of the highest awards from the Alzheimer’s Association – The Zenith Award (1994) and the Temple Award (1999).

Source:

Boston University Medical Center

Master years were filed conformity the neuroquant level severity damaged ~ the agency of cortechs labs, inc if this year is associated, it would severity of the violence.

Both comments and pings are currently closed.